REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/26/2026
Back to search
Official data from USPTO
JARI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
01/27/2026
Trademark type
Combined
Nice classes
5
Filing date
10/22/2019
Registration date
01/26/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/26/2021
Last transaction
01/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
Jiangsu Province, CN
Examiner
CORWIN, KEVIN SCOTT
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of four Latin letters "JARI".
Holders and representatives
Holders
Jiangsu Automation Research Institute
Representatives
Kevin O'Keefe
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical reagents for medical or veterinary purposes; medical analgesic preparations; medicines for alleviating constipation; pharmaceutical agents affecting digestive organs; Nerve tranquilizers; Laxatives; Medical ointmentmedicated ointments for treating dermatological conditions; Sedatives; Sleeping pills; Medical biological preparations for the treatment of cancerhigh blood pressure; Medicinal chemical preparations for the treatment of cancerhigh blood pressure; Medical chemical preparationsmedicinal preparations for the treatment of cancerhigh blood pressure; Medical enzymesenzymes for medical purposes; Injectable solutions for medical purposesinjectable pharmaceuticals for treatment of cancerhigh blood pressure; Pharmaceuticals in tablet form for the treatment of cancerhigh blood pressure; Tincture of iodine; Medical liquid in the nature of injectable solutions for medical purposesinjectable pharmaceuticals for treatment of cancerhigh blood pressure; Ointment for medical usemedicated ointments for the treatment of cancerhigh blood pressure; Gelatin capsule for medicinepharmaceuticals for the treatment of cancerhigh blood pressure; medical X-ray contrast agent; Diagnostic preparations for medical purposes
Publications
History of USPTO decisions and trademark events.
28 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/07/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/30/2021
FIMP
FINAL DISPOSITION PROCESSED
04/30/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2020
PUBO
PUBLISHED FOR OPPOSITION
11/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/21/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/24/2020
ACEC
AMENDMENT FROM APPLICANT ENTERED
08/24/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/24/2020
ALIE
ASSIGNED TO LIE
08/21/2020
RFNT
REFUSAL PROCESSED BY IB
08/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/20/2020
RFRR
REFUSAL PROCESSED BY MPU
07/20/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/14/2020
CNRT
NON-FINAL ACTION WRITTEN
06/13/2020
MAFR
APPLICATION FILING RECEIPT MAILED
06/09/2020
DOCK
ASSIGNED TO EXAMINER
06/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/05/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/04/2020
Continuous trademark protection
Get notified about every new filing that threatens JARI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.